184 related articles for article (PubMed ID: 24328742)
1. Murine b7-h3 is a co-stimulatory molecule for T cell activation.
Yan R; Yang S; Gu A; Zhan F; He C; Qin C; Zhang X; Feng P
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):395-8. PubMed ID: 24328742
[TBL] [Abstract][Full Text] [Related]
2. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.
Hashiguchi M; Kobori H; Ritprajak P; Kamimura Y; Kozono H; Azuma M
Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10495-500. PubMed ID: 18650384
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
[TBL] [Abstract][Full Text] [Related]
4. B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.
Leitner J; Klauser C; Pickl WF; Stöckl J; Majdic O; Bardet AF; Kreil DP; Dong C; Yamazaki T; Zlabinger G; Pfistershammer K; Steinberger P
Eur J Immunol; 2009 Jul; 39(7):1754-64. PubMed ID: 19544488
[TBL] [Abstract][Full Text] [Related]
5. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
[TBL] [Abstract][Full Text] [Related]
6. Murine B7-H3 is a negative regulator of T cells.
Prasad DV; Nguyen T; Li Z; Yang Y; Duong J; Wang Y; Dong C
J Immunol; 2004 Aug; 173(4):2500-6. PubMed ID: 15294965
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activation.
Chen W; Hou Z; Li C; Xiong S; Liu H
PLoS One; 2011; 6(6):e21341. PubMed ID: 21738638
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 in tumors: friend or foe for tumor immunity?
Li G; Quan Y; Che F; Wang L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):245-253. PubMed ID: 29299639
[TBL] [Abstract][Full Text] [Related]
9. T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG; Parra E; Varga M; Kalland T; Sjogren HO; Hedlund G; Dohlsten M
Crit Rev Immunol; 2017; 37(2-6):463-481. PubMed ID: 29773030
[TBL] [Abstract][Full Text] [Related]
10. Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses.
Ueno T; Yeung MY; McGrath M; Yang S; Zaman N; Snawder B; Padera RF; Magee CN; Gorbatov R; Hashiguchi M; Azuma M; Freeman GJ; Sayegh MH; Najafian N
Eur J Immunol; 2012 Sep; 42(9):2343-53. PubMed ID: 22733595
[TBL] [Abstract][Full Text] [Related]
11. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response.
Chen C; Shen Y; Qu QX; Chen XQ; Zhang XG; Huang JA
Exp Cell Res; 2013 Jan; 319(1):96-102. PubMed ID: 22999863
[TBL] [Abstract][Full Text] [Related]
12. A novel monoclonal antibody against mouse B7-H3 developed in rats.
Yan R; Yang S; Sun J; Chen X; Zhang G; Feng P; Zhang X
Hybridoma (Larchmt); 2012 Aug; 31(4):267-71. PubMed ID: 22894780
[TBL] [Abstract][Full Text] [Related]
13. [Expression of mouse B7-H3-Fc fusion protein and characterization of its bioactivity].
Yan RH; Zhang GB; Sun J; Fu FQ; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Nov; 26(11):1067-9. PubMed ID: 21055342
[TBL] [Abstract][Full Text] [Related]
14. CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.
Majzner RG; Theruvath JL; Nellan A; Heitzeneder S; Cui Y; Mount CW; Rietberg SP; Linde MH; Xu P; Rota C; Sotillo E; Labanieh L; Lee DW; Orentas RJ; Dimitrov DS; Zhu Z; Croix BS; Delaidelli A; Sekunova A; Bonvini E; Mitra SS; Quezado MM; Majeti R; Monje M; Sorensen PHB; Maris JM; Mackall CL
Clin Cancer Res; 2019 Apr; 25(8):2560-2574. PubMed ID: 30655315
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mouse and human B7-H3 genes.
Sun M; Richards S; Prasad DV; Mai XM; Rudensky A; Dong C
J Immunol; 2002 Jun; 168(12):6294-7. PubMed ID: 12055244
[TBL] [Abstract][Full Text] [Related]
16. Structure and T cell inhibition properties of B7 family member, B7-H3.
Vigdorovich V; Ramagopal UA; Lázár-Molnár E; Sylvestre E; Lee JS; Hofmeyer KA; Zang X; Nathenson SG; Almo SC
Structure; 2013 May; 21(5):707-17. PubMed ID: 23583036
[TBL] [Abstract][Full Text] [Related]
17. B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets.
Luo L; Zhu G; Xu H; Yao S; Zhou G; Zhu Y; Tamada K; Huang L; Flies AD; Broadwater M; Ruff W; van Deursen JM; Melero I; Zhu Z; Chen L
PLoS One; 2015; 10(6):e0130126. PubMed ID: 26065426
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.
Steinberger P; Majdic O; Derdak SV; Pfistershammer K; Kirchberger S; Klauser C; Zlabinger G; Pickl WF; Stöckl J; Knapp W
J Immunol; 2004 Feb; 172(4):2352-9. PubMed ID: 14764704
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
[TBL] [Abstract][Full Text] [Related]
20. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection.
Luan Y; Ju J; Luo L; Zhang Z; Wang J; Zhu DM; Cheng L; Zhang SY; Chen L; Wang FS; Wang S
J Viral Hepat; 2012 Jan; 19(1):23-31. PubMed ID: 22187944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
